Skip to main content

Changes in Non-Diabetic Comorbid Disease Status Following Laparoscopic Vertical Sleeve Gastrectomy (LVSG) Versus Laparoscopic Roux-En-Y Gastric Bypass (LRYGB) Procedures: a Systematic Review of Randomized Controlled Trials

Abstract

Purpose

Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical sleeve gastrectomy (LVSG) have been proposed as cost-effective strategies to manage obesity-related chronic disease. The aim of this systematic review was to study the peer review literature regarding postoperative nondiabetic comorbid disease resolution or improvement reported from randomized controlled trials (RCTs) comparing LVSG and LRYGB procedures.

Material and Methods

RCTs comparing postoperative comorbid disease resolution such as hypertension, dyslipidemia, obstructive sleep apnea, joint and musculoskeletal conditions, gastroesophageal reflux disease, and menstrual irregularities following LVSG and LRYGB were included for analysis. The studies were selected from PubMed, Medline, EMBASE, Science Citation Index, Current Contents, and the Cochrane database and reported on at least one comorbidity resolution or improvement. The present work was undertaken according to the Preferred Reporting Items of Systematic Reviews and Meta-Analyses (PRISMA). The Jadad method for assessment of methodological quality was applied to the included studies.

Results

Six RCTs performed between 2005 and 2015 involving a total of 695 patients (LVSG n = 347, LRYGB n = 348) reported on the resolution or improvement of comorbid disease following LVSG and LRYGB procedures. Both bariatric procedures provide effective and almost comparable results in improving or resolving these comorbidities.

Conclusions

This systematic review of RCTs suggests that both LVSG and LRYGB are effective in resolving or improving preoperative nondiabetic comorbid diseases in obese patients. While results are not conclusive at this time, LRYGB may provide superior results compared to LVSG in mediating the remission and/or improvement in some conditions such as dyslipidemia and arthritis.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Preventative Health Taskforce. Australia: the healthiest country by 2020. In: Obesity Working Group, ed. Technical report 1. Obesity in Australia: a need for urgent action, including addendum for October 2008 to June 2009. Canberra: Australian Government, 2009.

  2. 2.

    Sassi FMD, Checchini M, et al. The obesity epidemic: analysis of past and projected future trends in selected OECD countries. OECD Health working paper no. 45. Paris: OECD, 2009.

  3. 3.

    United Health Foundation, American Public Health Association, Prevention Pf. The future costs of obesity: national and state estimates of the impact of obesity on direct health care expenses, 2009.

  4. 4.

    Colagiuri S, Lee CM, Colagiuri R, et al. The cost of overweight and obesity in Australia. Med J Aust. 2010;192(5):260–4.

    PubMed  Google Scholar 

  5. 5.

    Borisenko O, Adam D, Funch-Jensen P, et al. Bariatric surgery can lead to net cost savings to health care systems: results from a comprehensive European decision analytic model. Obes Surg. 2015;25(9):1559–68.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. The Cochrane database of systematic reviews. 2014;8:CD003641.

    Google Scholar 

  7. 7.

    Organisation for Economic and Cooperation Development. Obesity update secondary obesity. Update 2014. http://www.worldobesity.org/resources/aboutobesity/.

  8. 8.

    Picot J, Jones J, Colquitt JL, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13(41):1-190–215-357. iii-iv

    Article  Google Scholar 

  9. 9.

    Suter M, Donadini A, Romy S, et al. Laparoscopic Roux-en-Y gastric bypass: significant long-term weight loss, improvement of obesity-related comorbidities and quality of life. Ann Surg. 2011;254(2):267–73.

    Article  PubMed  Google Scholar 

  10. 10.

    Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nature reviews Gastroenterology & hepatology. 2013;10(10):575–84.

    Article  Google Scholar 

  11. 11.

    Makaronidis JM, Batterham RL. Potential mechanisms mediating sustained weight loss following Roux-en-Y gastric bypass and sleeve gastrectomy. Endocrinol Metab Clin N Am. 2016;45(3):539–52.

    Article  Google Scholar 

  12. 12.

    Osland E, Yunus RM, Khan S, et al. Postoperative early major and minor complications in laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a meta-analysis and systematic review. Obes Surg. 2016;26(10):2273–84.

    Article  PubMed  Google Scholar 

  13. 13.

    Osland E, Yunus RM, Khan S, et al. Late postoperative complications in laparoscopic sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB): meta-analysis and systematic review. Surgical laparoscopy, endoscopy & percutaneous techniques. 2016;26(3):193–201.

    Article  Google Scholar 

  14. 14.

    Osland E, Yunus RM, Khan S, et al. Diabetes improvement and resolution following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials. Surgical endoscopy 2016 Sep 13. [Epub ahead of print].

  15. 15.

    Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13(6):861–4.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Biter LU, Gadiot RP, Grotenhuis BA, et al. The Sleeve Bypass Trial: a multicentre randomized controlled trial comparing the long term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC obesity. 2015;2:30.

    Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Fischer L, Wekerle AL, Bruckner T, et al. BariSurg trial: sleeve gastrectomy versus Roux-en-Y gastric bypass in obese patients with BMI 35-60 kg/m2—a multi-centre randomized patient and observer blind non-inferiority trial. BMC Surg. 2015;15:87.

    Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Yang J, Wang C, Cao G, et al. Long-term effects of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m2. BMC Surg. 2015;15:88.

    Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Zhang Y, Zhao H, Cao Z, et al. A randomized clinical trial of laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy for the treatment of morbid obesity in China: a 5-year outcome. Obes Surg. 2014;24(10):1617–24.

    Article  PubMed  Google Scholar 

  21. 21.

    Peterli R, Borbely Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690–4. discussion 95

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Helmio M, Victorzon M, Ovaska J, et al. Comparison of short-term outcome of laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: a prospective randomized controlled multicenter SLEEVEPASS study with 6-month follow-up. Scandinavian journal of surgery : SJS: official organ for the Finnish Surgical Society and the Scandinavian Surgical Society. 2014;103(3):175–81.

    CAS  Google Scholar 

  23. 23.

    Kehagias I, Karamanakos SN, Argentou M, et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg. 2011;21(11):1650–6.

    Article  PubMed  Google Scholar 

  24. 24.

    de Barros F, Setubal S, Martinho JM, et al. Early endocrine and metabolic changes after bariatric surgery in grade III morbidly obese patients: a randomized clinical trial comparing sleeve gastrectomy and gastric bypass. Metab Syndr Relat Disord. 2015;13(6):264–71.

    Article  PubMed  Google Scholar 

  25. 25.

    Woelnerhanssen B, Peterli R, Steinert RE, et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery. 2011;7(5):561–8.

    Article  Google Scholar 

  26. 26.

    Peterli R, Wolnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250(2):234–41.

    Article  PubMed  Google Scholar 

  27. 27.

    Harsha DW, Bray GA. Weight loss and blood pressure control (Pro). Hypertension. 2008;51(6):1420–5. discussion 25

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968–77.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978;240(15):1607–10.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333(11):677–85.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Neal B, MacMahon S, Chapman N, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356(9246):1955–64.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Zhang C, Yuan Y, Qiu C, et al. A meta-analysis of 2-year effect after surgery: laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg. 2014;24(9):1528–35.

    Article  PubMed  Google Scholar 

  33. 33.

    Li J, Lai D, Wu D. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26(2):429–42.

    Article  PubMed  Google Scholar 

  34. 34.

    Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obes Surg. 2015;25(1):19–26.

    Article  PubMed  Google Scholar 

  35. 35.

    Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1—executive summary. J Clin Lipidol. 2014;8(5):473–88.

    Article  PubMed  Google Scholar 

  36. 36.

    Mathers CD, Boerma T, Ma FD. Global and regional causes of death. Br Med Bull. 2009;92:7–32.

    Article  PubMed  Google Scholar 

  37. 37.

    Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Sctivity, and Metabolism. Circulation. 2006;113(6):898–918.

    Article  PubMed  Google Scholar 

  38. 38.

    Bays HE, Toth PP, Kris-Etherton PM, et al. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7(4):304–83.

    Article  PubMed  Google Scholar 

  39. 39.

    Bays HE, Jones PH, Jacobson TA, et al. Lipids and bariatric procedures part 1 of 2: scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: executive summary. J Clin Lipidol. 2016;10(1):15–32.

    Article  PubMed  Google Scholar 

  40. 40.

    Wang MC, Guo XH, Zhang YW, et al. Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Am Surg. 2015;81(2):166–71.

    PubMed  Google Scholar 

  41. 41.

    DuPree CE, Blair K, Steele SR, et al. Laparoscopic sleeve gastrectomy in patients with preexisting gastroesophageal reflux disease: a national analysis. JAMA Surg. 2014;149(4):328–34.

    Article  PubMed  Google Scholar 

  42. 42.

    Iossi MF, Konstantakos EK, Teel 2nd DD, et al. Musculoskeletal function following bariatric surgery. Obesity. 2013;21(6):1104–10.

    Article  PubMed  Google Scholar 

  43. 43.

    Hooper MM, Stellato TA, Hallowell PT, et al. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes. 2007;31(1):114–20.

    CAS  Article  Google Scholar 

  44. 44.

    Williams SE. Metabolic bone disease in the bariatric surgery patient. J Obes. 2011;2011:634614.

    Article  PubMed  Google Scholar 

  45. 45.

    Cowan DC, Livingston E. Obstructive sleep apnoea syndrome and weight loss: review. Sleep Disord. 2012;2012:163296.

    Article  PubMed  PubMed Central  Google Scholar 

  46. 46.

    Teitelman M, Grotegut CA, Williams NN, et al. The impact of bariatric surgery on menstrual patterns. Obes Surg. 2006;16(11):1457–63.

    Article  PubMed  Google Scholar 

  47. 47.

    Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review of the clinical and economic evidence. J Gen Intern Med. 2011;26(10):1183–94.

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Major P, Matlok M, Pedziwiatr M, et al. Quality of life after bariatric surgery. Obes Surg. 2015;25(9):1703–10.

    Article  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Nadalini L, Zenti MG, Masotto L, et al. Improved quality of life after bariatric surgery in morbidly obese patients. Interdisciplinary group of bariatric surgery of Verona (G.I.C.O.V.). Il Giornale di chirurgia. 2014;35(7–8):161–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg. 2011;146(2):149–55.

    Article  PubMed  Google Scholar 

  51. 51.

    Laurino Neto RM, Herbella FA. Changes in quality of life after short and long term follow-up of Roux-en-Y gastric bypass for morbid obesity. Arq Gastroenterol. 2013;50(3):186–90.

    Article  PubMed  Google Scholar 

  52. 52.

    Julia C, Ciangura C, Capuron L, et al. Quality of life after Roux-en-Y gastric bypass and changes in body mass index and obesity-related comorbidities. Diabetes & metabolism. 2013;39(2):148–54.

    CAS  Article  Google Scholar 

  53. 53.

    Bennett JC, Wang H, Schirmer BD, et al. Quality of life and resolution of co-morbidities in super-obese patients remaining morbidly obese after Roux-en-Y gastric bypass. Surgery for obesity and related diseases: official journal of the American Society for Bariatric Surgery. 2007;3(3):387–91.

    Article  Google Scholar 

  54. 54.

    Oh SH, Song HJ, Kwon JW, et al. The improvement of quality of life in patients treated with bariatric surgery in Korea. Journal of the Korean Surgical Society. 2013;84(3):131–9.

    Article  PubMed  PubMed Central  Google Scholar 

  55. 55.

    O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144(9):625–33.

    Article  PubMed  Google Scholar 

  56. 56.

    Karlsen TI, Lund RS, Roislien J, et al. Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study. Health and quality of life outcomes. 2013;11:17.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Muhammed Ashraf Memon.

Ethics declarations

Conflict of Interest

EO declares no conflict of interest.

RMY declares no conflict of interest.

SK declares no conflict of interest.

BM declares no conflict of interest.

MAM declares no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed Consent

Does not apply

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Osland, E., Yunus, R.M., Khan, S. et al. Changes in Non-Diabetic Comorbid Disease Status Following Laparoscopic Vertical Sleeve Gastrectomy (LVSG) Versus Laparoscopic Roux-En-Y Gastric Bypass (LRYGB) Procedures: a Systematic Review of Randomized Controlled Trials. OBES SURG 27, 1208–1221 (2017). https://doi.org/10.1007/s11695-016-2469-5

Download citation

Keywords

  • Obesity
  • Laparoscopic
  • Sleeve gastrectomy
  • Roux-en-Y gastric bypass
  • Hypertension
  • Dyslipidemia
  • Musculoskeletal disorders
  • Obstructive sleep apnea
  • Gastroesophageal reflux disease
  • Menstrual irregularities
  • Systematic review
  • Randomized controlled trials